An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
Condition(s):Post-Traumatic Stress DisorderLast Updated:June 6, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Post-Traumatic Stress DisorderLast Updated:June 6, 2023Recruiting
Condition(s):Pain; Stiffness; Abnormal Gait; BalanceLast Updated:June 28, 2012Unknown status
Condition(s):Auditory Perceptual Impairment; AgingLast Updated:May 17, 2023Recruiting
Condition(s):Excessive Daytime Sleepiness; NarcolepsyLast Updated:May 9, 2014Completed
Condition(s):Postpartum DepressionLast Updated:November 1, 2023Recruiting
Condition(s):Delirium; Cognitive Impairment; Alzheimer; Early Onset; Trauma; Polytrauma; Traumatic Brain Injury; ICU; Critical IllnessLast Updated:October 18, 2023Active, not recruiting
Condition(s):Fatigue; Multiple SclerosisLast Updated:April 22, 2022Not yet recruiting
Condition(s):Inflammation; Cognitive Impairment; Anxiety; Alcohol DrinkingLast Updated:December 11, 2023Recruiting
Condition(s):Alzheimer DiseaseLast Updated:March 20, 2024Not yet recruiting
Condition(s):Psychological Adjustment; Compassion; Chronic DiseaseLast Updated:November 8, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.